ImmunoPrecise Antibodies Ltd is a biotechnology business based in the US. ImmunoPrecise Antibodies shares (IPA) are listed on the NASDAQ and all prices are listed in US Dollars.
How to buy shares in ImmunoPrecise Antibodies
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – IPA – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
ImmunoPrecise Antibodies stock price (NASDAQ: IPA)Use our graph to track the performance of IPA stocks over time.
ImmunoPrecise Antibodies shares at a glance
|Latest market close||$7.82|
|52-week range||$1.00 - $33.34|
|50-day moving average||$6.31|
|200-day moving average||$10.48|
|Wall St. target price||N/A|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||N/A|
Buy ImmunoPrecise Antibodies shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy ImmunoPrecise Antibodies stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
ImmunoPrecise Antibodies price performance over time
|1 week (2021-07-15)||N/A|
|1 month (2021-06-25)||21.43%|
|3 months (2021-04-26)||-17.34%|
|6 months (2021-01-22)||N/A|
|1 year (2020-07-22)||N/A|
|2 years (2019-07-22)||N/A|
|3 years (2018-07-22)||N/A|
|5 years (2016-07-22)||N/A|
ImmunoPrecise Antibodies financials
|Revenue TTM||$17.2 million|
|Gross profit TTM||$8 million|
|Return on assets TTM||-9.68%|
|Return on equity TTM||-13.93%|
|Market capitalisation||$252.2 million|
TTM: trailing 12 months
Shorting ImmunoPrecise Antibodies shares
There are currently 146,987 ImmunoPrecise Antibodies shares held short by investors – that's known as ImmunoPrecise Antibodies's "short interest". This figure is 18.2% up from 124,385 last month.
There are a few different ways that this level of interest in shorting ImmunoPrecise Antibodies shares can be evaluated.
ImmunoPrecise Antibodies's "short interest ratio" (SIR)
ImmunoPrecise Antibodies's "short interest ratio" (SIR) is the quantity of ImmunoPrecise Antibodies shares currently shorted divided by the average quantity of ImmunoPrecise Antibodies shares traded daily (recently around 51938.869257951). ImmunoPrecise Antibodies's SIR currently stands at 2.83. In other words for every 100,000 ImmunoPrecise Antibodies shares traded daily on the market, roughly 2830 shares are currently held short.
To gain some more context, you can compare ImmunoPrecise Antibodies's short interest ratio against those of similar companies.
However ImmunoPrecise Antibodies's short interest can also be evaluated against the total number of ImmunoPrecise Antibodies shares, or, against the total number of tradable ImmunoPrecise Antibodies shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case ImmunoPrecise Antibodies's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 ImmunoPrecise Antibodies shares in existence, roughly 10 shares are currently held short) or 0.0086% of the tradable shares (for every 100,000 tradable ImmunoPrecise Antibodies shares, roughly 9 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against ImmunoPrecise Antibodies.
Find out more about how you can short ImmunoPrecise Antibodies stock.
ImmunoPrecise Antibodies share dividends
We're not expecting ImmunoPrecise Antibodies to pay a dividend over the next 12 months.
You may also wish to consider:
- Amgen (AMGN.US) (2.68% forward annual dividend yield)
Have ImmunoPrecise Antibodies's shares ever split?
ImmunoPrecise Antibodies's shares were split on a 4:1 basis on 29 May 2013. So if you had owned 1 share the day before before the split, the next day you'd have owned 4 shares. This wouldn't directly have changed the overall worth of your ImmunoPrecise Antibodies shares – just the quantity. However, indirectly, the new 75% lower share price could have impacted the market appetite for ImmunoPrecise Antibodies shares which in turn could have impacted ImmunoPrecise Antibodies's share price.
ImmunoPrecise Antibodies share price volatility
Over the last 12 months, ImmunoPrecise Antibodies's shares have ranged in value from as little as $1 up to $33.34. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ImmunoPrecise Antibodies's is -0.2368. This would suggest that ImmunoPrecise Antibodies's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, ImmunoPrecise Antibodies has bucked the trend.
To put ImmunoPrecise Antibodies's beta into context you can compare it against those of similar companies.
ImmunoPrecise Antibodies overview
ImmunoPrecise Antibodies Ltd. , together with its subsidiaries, engages in the antibody production and related services in the United States, Canada, Europe, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune and naive phage display production and screening; hybridoma production with screening and clone-picking; transgenic animals and multi-species antibody discovery; antibody characterization studies, such as affinity measurements, functional assays and epitope mapping, and binning; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA synthesis and cloning, protein and antibody downstream processing; antibody engineering; transient and stable cell line generation; antibody optimization and humanization; and cryopreservation. The company has collaboration with Eurofins Discovery to develop antibody discovery platform. ImmunoPrecise Antibodies Ltd. was incorporated in 1983 and is based in Victoria, Canada.
Stocks similar to ImmunoPrecise Antibodies
ImmunoPrecise Antibodies in the news
32 Stocks Moving in Friday's Pre-Market Session
61 Biggest Movers From Yesterday
Mid-Afternoon Market Update: Dow Rises Over 50 Points; ImmunoPrecise Antibodies Shares Spike Higher
Frequently asked questionsWhat percentage of ImmunoPrecise Antibodies is owned by insiders or institutions?
Currently 6.727% of ImmunoPrecise Antibodies shares are held by insiders and 7.208% by institutions. When does the fiscal year end for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies's fiscal year ends in April. Where is ImmunoPrecise Antibodies based?
ImmunoPrecise Antibodies's address is: 3204?4464 Markham Street, Victoria, BC, Canada, V8Z 7X8
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy Hellenic Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert